Moreover, FAM222A-AS1 overexpression could highly activate AKT1/2 and GSK-3α/β signaling, implying that FAM222A-AS1 may promote CRC via a more complex signaling pathway. This evidence concerns the gene GSK3A and colorectal carcinoma.